Morgan Stanley’s iTeos Therapeutics ITOS Stock Holding History
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $4.28M | Buy |
429,340
+178,209
| +71% | +$1.78M | ﹤0.01% | 4182 |
|
|
2025
Q1 | $1.5M | Buy |
251,131
+514
| +0.2% | +$3.07K | ﹤0.01% | 4784 |
|
|
2024
Q4 | $1.92M | Sell |
250,617
-250,749
| -50% | -$1.93M | ﹤0.01% | 4721 |
|
|
2024
Q3 | $5.12M | Sell |
501,366
-587,933
| -54% | -$6M | ﹤0.01% | 3945 |
|
|
2024
Q2 | $16.2M | Sell |
1,089,299
-543,057
| -33% | -$8.06M | ﹤0.01% | 2892 |
|
|
2024
Q1 | $22.3M | Sell |
1,632,356
-630,630
| -28% | -$8.6M | ﹤0.01% | 2577 |
|
|
2023
Q4 | $24.8M | Buy |
2,262,986
+2,001,233
| +765% | +$21.9M | ﹤0.01% | 3142 |
|
|
2023
Q3 | $2.87M | Buy |
261,753
+85,073
| +48% | +$932K | ﹤0.01% | 4138 |
|
|
2023
Q2 | $2.34M | Sell |
176,680
-386,534
| -69% | -$5.12M | ﹤0.01% | 4319 |
|
|
2023
Q1 | $7.67M | Sell |
563,214
-283,645
| -33% | -$3.86M | ﹤0.01% | 3389 |
|
|
2022
Q4 | $16.5M | Buy |
846,859
+12,965
| +2% | +$253K | ﹤0.01% | 2539 |
|
|
2022
Q3 | $15.9M | Sell |
833,894
-219,340
| -21% | -$4.18M | ﹤0.01% | 2452 |
|
|
2022
Q2 | $21.7M | Buy |
1,053,234
+250,864
| +31% | +$5.17M | ﹤0.01% | 2199 |
|
|
2022
Q1 | $25.8M | Buy |
802,370
+638,371
| +389% | +$20.5M | ﹤0.01% | 1853 |
|
|
2021
Q4 | $7.64M | Buy |
163,999
+7,391
| +5% | +$344K | ﹤0.01% | 3249 |
|
|
2021
Q3 | $4.23M | Buy |
156,608
+65,256
| +71% | +$1.76M | ﹤0.01% | 3911 |
|
|
2021
Q2 | $2.34M | Buy |
91,352
+91,206
| +62,470% | +$2.34M | ﹤0.01% | 4509 |
|
|
2021
Q1 | $5K | Sell |
146
-8,307
| -98% | -$284K | ﹤0.01% | 7105 |
|
|
2020
Q4 | $286K | Buy |
8,453
+6,078
| +256% | +$206K | ﹤0.01% | 5402 |
|
|
2020
Q3 | $59K | Buy |
+2,375
| New | +$59K | ﹤0.01% | 5664 |
|